Zhejiang Starry Pharmaceutical Co.,Ltd.

XSSC:603520 Stock Report

Market Cap: CN¥4.7b

Zhejiang Starry PharmaceuticalLtd Future Growth

Future criteria checks 5/6

Zhejiang Starry PharmaceuticalLtd is forecast to grow earnings and revenue by 88.7% and 22.8% per annum respectively. EPS is expected to grow by 88.1% per annum. Return on equity is forecast to be 13% in 3 years.

Key information

88.7%

Earnings growth rate

88.1%

EPS growth rate

Pharmaceuticals earnings growth18.3%
Revenue growth rate22.8%
Future return on equity13.0%
Analyst coverage

Low

Last updated05 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603520 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,985467N/A6453
12/31/20253,240288N/A5973
12/31/20242,633108N/A4423
9/30/20242,37014-353-13N/A
6/30/20242,44332-148106N/A
3/31/20242,27247-104179N/A
12/31/20232,19644-22245N/A
9/30/20232,385-56-167113N/A
6/30/20232,273-105-28961N/A
3/31/20232,180-147-444-27N/A
12/31/20222,131-76-551-78N/A
9/30/20222,066124-427143N/A
6/30/20222,087232-334176N/A
3/31/20222,15333933427N/A
12/31/20212,000324205509N/A
9/30/20211,631260149303N/A
6/30/20211,50025565233N/A
3/31/20211,440258-8152N/A
12/31/20201,36723921174N/A
9/30/20201,37023131190N/A
6/30/20201,39521795262N/A
3/31/20201,30617584242N/A
12/31/20191,309170113247N/A
9/30/20191,24214672208N/A
6/30/20191,09812224138N/A
3/31/201998811266209N/A
12/31/20188909429192N/A
9/30/201879498-5134N/A
6/30/201874294N/A170N/A
3/31/201871277N/A69N/A
12/31/201771183N/A32N/A
9/30/201771284N/A35N/A
6/30/201771284N/A-22N/A
3/31/201769879N/A-4N/A
12/31/201667376N/A8N/A
9/30/201671681N/A34N/A
6/30/201669174N/A76N/A
3/31/201666160N/A37N/A
12/31/201569669N/A95N/A
12/31/201465868N/A144N/A
12/31/201368664N/A75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603520's forecast earnings growth (88.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 603520's earnings (88.7% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 603520's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603520's revenue (22.8% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 603520's revenue (22.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603520's Return on Equity is forecast to be low in 3 years time (13%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y